Did you know that the cost for cancer care is becoming unsustainable? In my quest to understand why thermography is not accepted as I believe it should be, I came across an article entitled, Cancer care shows ‘culture of excess’ featured in the Canadian Broadcasting Corporation (CBC)’s online news today discusses a report published in The Lancet Oncology on the unsustainable cost of managing cancer care in developed countries.
The CBC article quotes the authors stating, “In developed countries, cancer treatment is becoming a culture of excess. We overdiagnose, overtreat, and overpromise. This extends from use of complex technology, surgery, and drugs to events related to the acceptance of treatment side-effects.”
The report, published in the current issue of Lancet Oncology, examined cancer care costs in the US, UK, and Australia. It notes that cancer treatments in these countries account for 4%-7% of all healthcare spending, with costs likely only to rise as populations age, treatment costs increase, and treatments become more excessive. As costs rise, treatment becomes inequitable across populations. To shift away from this trend to unsustainability, the report makes two recommendations: reduce the cost of services, or reduce the number of people who need them.
Thermography, a pain free and radiation free measure, aids in the earliest detection of breast cancer. It is effective for all populations, employs sophisticated, yet cost-saving technology, and has absolutely no side effects.
As educated women, one in eight* of us cannot afford to wait for policy changes. Do the research and learn how medical infrared thermography can provide you with a warning system and risk assessment. For more information call me: 585-754-3315
(*Estimated number of American women who will develop breast cancer in their lifetime, according to the National Cancer Institute 2010 FactSheet)